<DOC>
	<DOC>NCT00135122</DOC>
	<brief_summary>The purpose of this study is to determine whether prednisolone is more effective than placebo in the first six days after initiation of medication withdrawal therapy for a medication overuse headache. Another purpose is to study whether patients followed by a neurologist 1 year after withdrawal do better than patients followed by a general practitioner.</brief_summary>
	<brief_title>Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache</brief_title>
	<detailed_description>Data published BoeMG,Mygland A,Salvesen R; Neurology 2007 Jul 3;69(1):26-31</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Headache Disorders, Secondary</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Chronic daily headache and medication overuse fulfilling International Headache Society (IHS)II criteria Pregnancy Age under 18 and over 70 years Major mental disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>migraine</keyword>
	<keyword>analgesics</keyword>
	<keyword>tension type headache</keyword>
</DOC>